EQT Healthcare Growth

Scaling Innovative Healthcare Champions

A buyout strategy dedicated to healthcare, EQT Healthcare Growth seeks to scale healthcare companies by building commercial muscle and expanding their global reach to generate attractive risk-adjusted returns and simultaneously deliver positive outcomes across the healthcare value chain.

At a glance

Equity tickets: 75-275M EUR
Portfolio companies: 2
Investment Advisory Professionals: 10+

Control investments in innovative, profitable healthcare companies with a strong growth outlook.

The acceleration of innovation, driven by strong secular growth factors, is expanding the opportunity to invest in innovative healthcare products and services that address the increasing demand for improved, more efficient, and accessible healthcare. Against this backdrop, EQT Healthcare Growth invests in mid-market opportunities in the same sub-sectors as EQT Equity, building on that strategy’s three-decade track record.

The dedicated EQT Healthcare Growth team is supported by an active Investment Committee including relevant senior EQT leaders and is an integral part of EQT’s global healthcare sector vertical and the broader Private Capital platform. The team combines the deep scientific expertise and ability to identify emerging trends from EQT Life Sciences with EQT Equity’s value creation playbook and 30-year track record in healthcare investing.

EQT’s 30-year healthcare track record: EQT has been investing in healthcare for 30 years. We have put over 23 billion euros into more than 200 healthcare companies, ranging from new startups to established businesses. EQT has a large, global team dedicated to healthcare, including 110 investment experts in 20 countries and a network of more than 150 top healthcare advisors. EQT is a significant private investor in healthcare. In the last ten years, nearly half of our Private Equity investments have been in healthcare companies.

Spotlight OnHealthcare Growth

See all

Opinion

The Transformative Impact of Healthcare Companies

Healthcare

5 Things Investors Should Know About Healthcare

Andrew RummerContributor

Opinion

Investors Must Put Patient Outcomes Ahead of Short-Term Gains

Explore Our Portfolio

See all

A leading provider of advanced statistics and AI-enabled software to manage risk and enhance data quality oversight in clinical trials

CluePoints is a leading Risk-Based Quality Management (“RBQM”) and Data Quality Oversight Software provider. CluePoints leverages advanced statistics, machine learning and artificial intelligence to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct.

See company page